The long-term objective of the proposed research is to understand molecular mechanisms of HIV-1 pathogenesis. Children receiving highly active antiretroviral therapy [HAART] with the protease inhibitor ritonavir display dramatic immunoreconstitution that produces rapid and sustained three- to ten-fold increases in both memory and naive CD4 T cell subsets. In the majority of children a significant reduction of greater then one log in viral burden accompanied immunoreconstitution, although virus levels were seldom reduced to undetectable. In contrast, about one-third of the children had limited virological response to HAART, even with dramatic immune reconstitution and improvement in clinical course. Genotypic drug resistance developed in viruses that emerged during antiviral therapy independent of changes in virus burden. Other characteristics of post therapy viruses, such as tropism, phenotype, levels of replication, host cell range, and dynamics of genetic variability in regions of the virus genome other than those targeted by the drugs, are not well studied, particularly in the pediatric population, and are the focus of the proposal. Research plan is designed to test the hypothesis that T cell reconstitution is influenced by the viruses, which emerge in response to HAART and are qualitatively different from pretherapy viruses. There are three specific aims: 1. To assess changes in biological phenotype and genetic complexity of M-tropic viruses that emerge in children treated with HAART. 2. To identify interactions between M-tropic viruses and naive or memory CD4 T cells in vivo which are associated with virus levels during HAART. 3. To identify mechanisms which contribute to significant differences in replicative ability of M-tropic viruses by using a novel approach to evaluate interactions between M-tropic virus envelope glycoproteins and chemokine receptors. The research plan includes novel approaches to assess quantitative interactions between viruses and host cells to understand mechanisms of pathogenesis in vivo. Results will provide new parameters that, in addition to viral burden, can be used to evaluate pathogenic potential of viruses that emerge in response to HAART in children and in adults. Factors that serve as predictors of immunoreconstitution are important for assessing the efficacy of HAART, as well as the efficacy strategies designed to augment immunoreconstitution or provide protection from infection.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD032259-06
Application #
6125675
Study Section
Special Emphasis Panel (ZRG5-ARRC (02))
Program Officer
Nugent, Robert
Project Start
1994-12-01
Project End
2002-11-30
Budget Start
1999-12-01
Budget End
2000-11-30
Support Year
6
Fiscal Year
2000
Total Cost
$311,065
Indirect Cost
Name
University of Florida
Department
Pathology
Type
Schools of Medicine
DUNS #
073130411
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Haraguchi, Soichi; Ho, Sarah K; Morrow, Matthew et al. (2011) Developmental regulation of P-glycoprotein activity within thymocytes results in increased anti-HIV protease inhibitor activity. J Leukoc Biol 90:653-60
Wallet, Mark A; Wallet, Shannon M; Guiulfo, Giorgio et al. (2010) IFNgamma primes macrophages for inflammatory activation by high molecular weight hyaluronan. Cell Immunol 262:84-8
Brown, Joseph; Wallet, Mark A; Krastins, Bryan et al. (2010) Proteome bioprofiles distinguish between M1 priming and activation states in human macrophages. J Leukoc Biol 87:655-62
Wallet, Mark A; Rodriguez, Carina A; Yin, Li et al. (2010) Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy. AIDS 24:1281-90
Lamers, Susanna L; Salemi, Marco; Galligan, Derek C et al. (2010) Human immunodeficiency virus-1 evolutionary patterns associated with pathogenic processes in the brain. J Neurovirol 16:230-41
Yin, Li; Kou, Zhong Chen; Rodriguez, Carina et al. (2009) Antiretroviral therapy restores diversity in the T-cell receptor Vbeta repertoire of CD4 T-cell subpopulations among human immunodeficiency virus type 1-infected children and adolescents. Clin Vaccine Immunol 16:1293-301
Lamers, Susanna L; Salemi, Marco; Galligan, Derek C et al. (2009) Extensive HIV-1 intra-host recombination is common in tissues with abnormal histopathology. PLoS One 4:e5065
Ho, Sarah K; Perez, Elena E; Rose, Stephanie L et al. (2009) Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor. AIDS 23:1631-40
Rodriguez, Carina A; Koch, Sarah; Goodenow, Maureen et al. (2008) Clinical implications of discordant viral and immune outcomes following protease inhibitor containing antiretroviral therapy for HIV-infected children. Immunol Res 40:271-86
Salemi, Marco; Goodenow, Maureen M; Montieri, Stefania et al. (2008) The HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries. AIDS Res Hum Retroviruses 24:771-9

Showing the most recent 10 out of 25 publications